Evidence map›Paper›PMID 37126052›Full record

ArticleAnnals of medicine2023

Impact of (long) COVID on athletes' performance: a prospective study in elite football players.

E Wezenbeek, S Denolf, J G Bourgois, R M Philippaerts, B De Winne, T M Willems, E Witvrouw, S Verstockt, J Schuermans

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

E WezenbeekDepartment of Rehabilitation Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-9303-6915
S Denolf
J G BourgoisDepartment of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-8972-1573
R M PhilippaertsRoyal Standard de Liège, Liège, Belgium.
B De WinneZulte Waregem, Waregem, Belgium.
T M Willems
E Witvrouw
S VerstocktDepartment of Electronics and Information Systems, Ghent University, Ghent, Belgium.ORCID 0000-0003-1094-2184
J Schuermans
Ghent University · BEGhent University Hospital · BERoyal Conservatory of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate possible persistent performance deficits after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in elite athletes.

methodsA prospective cohort study in three Belgian professional male football teams was performed during the 2020 - 2021 season. Participants were submitted to

resultsOf the 84 included participants, 22 were infected with SARS-CoV-2 during follow-up. At the first testing after infection (52.0 ± 11.2 days after positive PCR testing) significantly higher percentages of maximal heart rate (%HRmax) were seen - within the isolated group of infected players- during ( Aerobic performance seems compromised even weeks after infection. Simultaneously, anaerobic performance seemed to be spared. Because of the potential detrimental effects on the immune system, caution might be advised with high-intensity exposure until aerobic performance is restored.KEY MESSAGESElite football players' aerobic performance seems to be affected for weeks after they return to sports after a SARS-CoV-2 infection.Similarly, anaerobic performance tests showed no discernible changes between both before and after SARS-CoV-2 infections.Regular YYIR testing is recommended to monitor aerobic performance after SARS-CoV-2 infection.

Indexed as

Athletic PerformanceCOVID-19FootballAthletesHumansMaleProspective StudiesSARS-CoV-2Aerobic endurance capacityelite athleteslongitudinal cohort studyphysical performanceSARS-CoV-2 infectionYo-Yo test

Identifiers

PMID37126052
PMCPMC10134946
OpenAlexW4367049426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.